Stay updated on Nivolumab Post-chemoradiotherapy Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Post-chemoradiotherapy Clinical Trial page.

Latest updates to the Nivolumab Post-chemoradiotherapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedThe page has been updated to a newer ClinicalTrials.gov revision version (v3.5.3 instead of v3.5.2), reflecting a site update rather than any change to the underlying study information.SummaryDifference0.1%

- Check20 days agoChange DetectedOno Pharmaceutical Co., Ltd. is added as a collaborator with the standardized company name. The page revision is updated to v3.5.2, replacing the previous Ono Pharmaceutical Co. Ltd and revision v3.5.0.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check84 days agoChange DetectedThe site revision label in the footer was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check91 days agoChange DetectedThe update adds Revision: v3.4.1 and removes Revision: v3.4.0, indicating a metadata version change rather than changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Post-chemoradiotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-chemoradiotherapy Clinical Trial page.